Mackenzie Financial’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-21,878
| Closed | -$290K | – | 1717 |
|
|
2024
Q4 | $290K | Buy |
21,878
+17,643
| +417% | +$234K | ﹤0.01% | 1401 |
|
|
2024
Q3 | $42.3K | Buy |
4,235
+2,282
| +117% | +$22.8K | ﹤0.01% | 1546 |
|
|
2024
Q2 | $43.6K | Buy |
1,953
+941
| +93% | +$21K | ﹤0.01% | 1499 |
|
|
2024
Q1 | $59.5K | Sell |
1,012
-958
| -49% | -$56.3K | ﹤0.01% | 1469 |
|
|
2023
Q4 | $43.7K | Sell |
1,970
-90
| -4% | -$1.99K | ﹤0.01% | 1452 |
|
|
2023
Q3 | $38.1K | Buy |
2,060
+1,091
| +113% | +$20.2K | ﹤0.01% | 1429 |
|
|
2023
Q2 | $67.8K | Buy |
+969
| New | +$67.8K | ﹤0.01% | 1433 |
|
|
2022
Q4 | – | Sell |
-1,589
| Closed | -$517K | – | 1487 |
|
|
2022
Q3 | $517K | Buy |
+1,589
| New | +$517K | ﹤0.01% | 923 |
|
|
2020
Q3 | – | Sell |
-292
| Closed | -$295K | – | 1004 |
|
|
2020
Q2 | $295K | Buy |
292
+16
| +6% | +$16.2K | ﹤0.01% | 871 |
|
|
2020
Q1 | $240K | Buy |
+276
| New | +$240K | ﹤0.01% | 948 |
|